¿La quimioterapia neoadyuvante proporciona algún beneficio para la desescalada quirúrgica en el cáncer de mama HER2 (−) luminal B? by Aysegul Aktas, Meryem Gunay-Gurleyik, Fugen Aker, Yasar Kaan-Akgok, Elif Atag

Get full text

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma by Huseyin Salih SEMIZ, Emel Ebru PALA, Behzat CAN, Elif ATAG, Hatice GUNGOR, Muzaffer SANCI

Get full text

What Is Your Choice for Androgen Deprivation Therapy in Metastatic Prostate Carcinoma: Surgical or Medical? by Huseyin Salih Semiz, Erdem Kisa, Eda Caliskan Yildirim, Elif Atag, Mehmet Emin Arayici, Talha Muezzinoglu, Aziz Karaoglu

Get full text

The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrin... by Eda Caliskan Yildirim, Elif Atag, Ezgi Coban, Olcun Umit Unal, Abdussamet Celebi, Murat Keser, Mehmet Uzun, Merve Keskinkilic, Eda Tanrikulu Simsek, Murat Sari, Tugba Yavuzsen

Get full text